Equitable Holdings
EQH
$44.98
-0.68%
Equitable Holdings is a diversified financial services company operating primarily in the insurance and asset management sectors, providing retirement solutions, asset management, and wealth management services to individual and institutional clients. The company is a significant player in the annuities and retirement savings market, with its Retirement segment being the dominant revenue driver, and its Asset Management segment (AB) offering global investment services. The current investor narrative revolves around the company's ability to navigate volatile financial markets impacting its investment income and annuity liabilities, while recent headlines about substantial share repurchases signal management's confidence in its capital return strategy and commitment to shareholder value.…
EQH
Equitable Holdings
$44.98
Related headlines
Investment Opinion: Should I buy EQH Today?
The synthesized recommendation is Hold. The core thesis is that EQH presents a high-risk, high-potential-reward deep value situation, but the severe fundamental flaws and volatility necessitate a cautious stance until earnings stability is demonstrated.
Supporting this Hold rating are several conflicting data points: the valuation is compelling at a PS of 1.22x and EV/Sales of 0.99x, suggesting a significant margin of safety on a sales basis. Analyst sentiment is unanimously bullish among major firms, indicating professional confidence. The company generates substantial free cash flow ($737M TTM) to fund shareholder returns. However, these positives are counterbalanced by a negative trailing net margin (-11.83%), a catastrophic debt-to-equity ratio (-88.68), and a 9.5% YoY revenue decline, painting a picture of a broken business model.
The thesis would upgrade to a Buy if the company reports two consecutive quarters of stable, positive net income and shows progress in repairing its balance sheet, moving shareholder equity into positive territory. It would downgrade to a Sell if revenue decline accelerates beyond 15% YoY or if free cash flow turns negative, jeopardizing the buyback program. Relative to its own turbulent history, the stock appears fairly valued for its current risk profile, but is deeply undervalued compared to its historical norms—a discount that is justified by the present operational disarray.
Sign up to view all
EQH 12-Month Price Forecast
EQH is a bifurcated story where compelling valuation and capital return potential are locked in a vault of operational instability. The neutral stance reflects the high probability of continued volatility (base case 50%) rather than a clear directional move. The bullish analyst consensus is noteworthy but appears to be a call on mean reversion of both multiples and earnings, which is high-risk. Confidence is medium because the range of outcomes is exceptionally wide, from a 20%+ rally to a 30%+ decline. The stance would upgrade to bullish on evidence of sustained quarterly profitability and balance sheet repair. It would turn bearish if the next earnings report shows a return to massive losses or a collapse in free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $58.47 and implied upside of +30.0% versus the current price.
Average Target
$58.47
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$36 - $58
Analyst target range
Analyst coverage for EQH appears limited, with only 2 analysts providing estimates for revenue and EPS, suggesting this may be a less-followed mid-cap name within the financial sector. The consensus sentiment, based on recent institutional ratings, is bullish, with firms like Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays all maintaining 'Overweight' or 'Buy' ratings throughout early 2026, indicating professional analyst confidence in the company's strategy and valuation. The target price range implied by EPS estimates is wide, with a low of $11.19 and a high of $13.29 for estimated EPS, but a specific average price target is not provided; the recent reaffirmations and upgrades (e.g., JP Morgan moving from Neutral to Overweight in January 2026) suggest a positive shift in sentiment, though the limited number of covering analysts means price discovery may be less efficient and the stock could exhibit higher volatility due to lower institutional scrutiny.
Bulls vs Bears: EQH Investment Factors
The investment debate for EQH is a classic battle between deep value and fundamental instability. The bull case is anchored by a heavily discounted valuation (PS ~1.2x), strong analyst support, and a robust capital return program funded by solid free cash flow. The bear case is driven by extreme earnings and revenue volatility, a concerning balance sheet with negative equity, and persistent long-term price underperformance. Currently, the bearish evidence appears stronger due to the severity and persistence of the fundamental weaknesses, which the discounted valuation only partially offsets. The single most important tension is whether the company's volatile, market-sensitive earnings can stabilize sufficiently to justify its low sales multiple, or if the negative equity and erratic performance represent an existential risk that the market has correctly priced.
Bullish
- Analyst Consensus Bullish: Major institutions including Morgan Stanley, Wells Fargo, and JP Morgan maintain 'Overweight' or 'Buy' ratings, with JP Morgan upgrading from Neutral in January 2026. This professional confidence, despite recent volatility, suggests a belief in the company's underlying strategy and valuation.
- Deeply Discounted Valuation: The stock trades at a Price-to-Sales ratio of 1.22x and an EV/Sales of 0.99x, near the bottom of its multi-year historical range. This represents a significant discount from its peak PS ratio of 12.28x, potentially pricing in excessive pessimism.
- Strong Recent Momentum & ROE: The stock has surged 21.26% over the past three months, indicating a potential bottoming process. Furthermore, the company maintains a strong Return on Equity of 18.65%, demonstrating efficient use of its capital base to generate profits.
- Robust Free Cash Flow & Capital Return: The company generated $737 million in trailing twelve-month free cash flow, providing ample internal funding. Recent news highlights substantial share repurchases, signaling management's confidence and commitment to returning capital to shareholders.
Bearish
- Extreme Earnings Volatility: The company swung from a $1.309 billion net loss in Q3 2025 to a $215 million profit in Q4 2025, with a trailing net margin of -11.83%. This extreme inconsistency, driven by investment market swings, makes forecasting and valuation highly challenging.
- Severe Revenue Decline & Instability: Q4 2025 revenue of $3.277 billion represents a 9.5% year-over-year decline. The top-line has shown extreme quarterly swings from $3.904 billion to $1.45 billion, indicating fundamental instability in its core insurance and investment operations.
- Negative Shareholder Equity & High Debt: The balance sheet shows a debt-to-equity ratio of -88.68, indicating negative shareholder equity. This precarious financial structure raises significant long-term solvency questions and amplifies risk during market stress.
- Persistent Long-Term Underperformance: The stock is down 14.34% over the past year, underperforming the S&P 500 by over 39 percentage points. Trading near 45% of its 52-week range, it shows a clear downtrend despite recent short-term gains.
EQH Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -14.34%, significantly underperforming the S&P 500's 24.99% gain. As of the latest close of $45.29, the price is trading at approximately 45% of its 52-week range (between $35.195 and $56.61), positioning it much closer to its 52-week low, which suggests a potential value opportunity but also reflects persistent negative momentum and investor skepticism. Recent momentum shows a sharp but volatile recovery attempt, with the stock up 9.77% over the past month and 21.26% over the past three months, indicating a potential bottoming process or short-term mean reversion after a severe decline; however, this positive short-term move starkly contrasts with the negative longer-term trend, signaling high volatility and lack of a confirmed trend reversal. Key technical support is the 52-week low area near $35.20, while resistance lies at the 52-week high of $56.61; a sustained breakout above the recent recovery highs near $45.50 could signal a more durable recovery, whereas a breakdown below $35 would confirm a continuation of the bear trend. The stock's beta of 1.108 indicates it is roughly 11% more volatile than the broader market, which is relevant for risk assessment given its recent price swings and 37.01% maximum drawdown.
Beta
1.11
1.11x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$57
Price range past year
Annual Return
-15.6%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | +5.6% | -0.2% |
| 3m | +19.7% | +14.0% |
| 6m | -7.7% | +7.8% |
| 1y | -15.6% | +25.3% |
| ytd | -6.2% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue growth is highly volatile and recently negative, with Q4 2025 revenue of $3.277 billion representing a 9.5% year-over-year decline; the multi-quarter trend shows extreme swings, from $3.904 billion in Q1 2025 to a low of $1.45 billion in Q3 2025, indicating significant instability in top-line performance likely tied to investment market fluctuations and insurance contract valuations. Profitability is inconsistent, with the company reporting net income of $215 million and a gross margin of 88.07% in Q4 2025, but swinging to a massive net loss of $1.309 billion in Q3 2025; the trailing twelve-month net margin is negative at -11.83%, highlighting earnings volatility, while the operating margin for the latest quarter was 10.5%, showing the core business can be profitable amidst investment-related charges. The balance sheet and cash flow picture is mixed, with a strong return on equity of 18.65% but a concerning debt-to-equity ratio of -88.68 (indicating negative shareholder equity); the company generated $737 million in trailing twelve-month free cash flow, providing internal funding for dividends and buybacks, but the negative equity raises questions about long-term financial structure and risk, especially given the volatile operating cash flows which were negative $80 million in the latest quarter.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$737000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Given the inconsistent profitability with a trailing net income that is negative on an annualized basis, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 1.22x and an Enterprise Value-to-Sales (EV/Sales) of 0.99x, both suggesting a modest sales multiple. Compared to industry averages, specific data is not available in the provided dataset for a direct peer comparison; however, a PS ratio around 1.2x for a financial services firm with a significant asset management business could be considered reasonable or potentially discounted if growth prospects are stable. Historically, the stock's own PS ratio has fluctuated wildly, from a high of 12.28x in Q1 2021 to recent lows around 1.22x; the current PS ratio is near the bottom of its multi-year historical range, which may indicate the market is pricing in significant fundamental deterioration or pessimism, presenting a potential value scenario if operations stabilize.
PE
-9.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -25x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-85.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on balance sheet fragility and earnings unpredictability. The negative shareholder equity (Debt/Equity of -88.68) is a critical red flag, suggesting the company's liabilities exceed its assets on a book-value basis, which could limit financial flexibility. Furthermore, the extreme earnings volatility—swinging from a $1.3 billion loss to a $215 million profit in consecutive quarters—creates immense forecasting uncertainty and calls into question the sustainability of its 18.65% ROE. Revenue is also highly unstable, with a 9.5% YoY decline in Q4 and wild quarterly swings, indicating deep sensitivity to financial market conditions that it cannot control.
Market & Competitive Risks are elevated by the stock's high volatility (beta of 1.108) and its valuation compression from historical highs. The stock trades at a fraction of its peak PS multiple, but remains vulnerable to further de-rating if the insurance and asset management sectors face headwinds like prolonged low interest rates or market downturns. Limited analyst coverage (only 2 providing estimates) reduces institutional scrutiny and can lead to less efficient price discovery, potentially exacerbating volatility. The company's performance is intrinsically linked to financial markets, making it a proxy for broader economic sentiment and susceptible to sector rotations away from financials.
The Worst-Case Scenario involves a severe market downturn triggering large investment losses in its insurance portfolio, exacerbating the negative equity position and leading to a liquidity crisis. This could force asset fire sales, a dividend cut, or a dilutive capital raise. Quantifying the downside, the stock could realistically retest its 52-week low of $35.20, representing a -22% decline from the current price of ~$45.29. A breach of that level could see a fall towards the $30 range, aligning with a maximum drawdown scenario similar to its historical -37.01%. An investor could face a loss of 22-35% in such an adverse environment.
FAQ
The key risks are, in order of severity: 1) Balance Sheet Risk: The negative shareholder equity (Debt/Equity of -88.68) creates solvency concerns and limits financial flexibility. 2) Earnings Volatility Risk: The company's profits are highly unstable, swinging from a $1.3B loss to a $215M profit quarter-to-quarter, making it unreliable. 3) Market Sensitivity Risk: With a beta of 1.108, the stock is highly correlated to and more volatile than the broader market, exposing it to macro downturns. 4) Revenue Decline Risk: Revenue fell 9.5% YoY in the last quarter and shows extreme quarterly instability, questioning the health of its core business.
The 12-month forecast for EQH is a wide range of outcomes with a neutral base case. The bull case (25% probability) targets $52-$56, driven by earnings stabilization and multiple expansion. The base case (50% probability) targets $42-$48, expecting continued volatile, range-bound trading. The bear case (25% probability) targets $30-$35, anticipating a fundamental deterioration and a test of new lows. The base case is most likely, predicated on the assumption that the company's extreme volatility persists without triggering a full-scale crisis, leading to sideways price action as buybacks provide a floor but fundamental concerns cap the ceiling.
EQH is deeply undervalued based on its historical trading multiples but may be fairly valued or even overvalued given its current fundamental deterioration. The stock trades at a Price-to-Sales ratio of 1.22x, a fraction of its peak over 12x. However, this discount reflects real problems: negative trailing net margin (-11.83%) and negative shareholder equity. Compared to a stable financial peer, it might look cheap, but the market is pricing in significant risk of further operational decline. The valuation implies the market expects continued volatility and has little confidence in sustainable profitability.
EQH is a high-risk, high-potential-reward stock that is not a good buy for most conservative investors. For a speculative investor comfortable with volatility, it presents a compelling deep-value case, trading at a PS ratio of 1.22x near its historical lows with unanimous bullish analyst ratings. The potential 15-25% upside to the base case target is attractive, but it is counterbalanced by severe risks including negative shareholder equity and a history of massive quarterly losses. It could be a good buy for a small, risk-capital portion of a portfolio if the investor believes the company's fundamentals are bottoming.
EQH is unsuitable for short-term trading due to its high volatility (beta 1.108) and unpredictable earnings, which can lead to sharp, news-driven moves. It is theoretically a long-term investment for investors betting on a multi-year turnaround, but this carries substantial risk given the balance sheet issues. The company does pay a small dividend (2.64% yield), but this is not sufficient to justify a pure income hold. A minimum holding period of 2-3 years is suggested to see if management can execute a stabilization plan, making it suitable only for patient, risk-tolerant investors with a long-term, speculative allocation.